Insulet Corporation Peer Comparison
Metric | Value | Ranking | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Market Cap | $22.8 Billion | 5/16 | ABT $234.5B |
SYK $150.7B |
EW $45.8B |
DXCM $33.5B |
PODD $22.8B |
ALGN $13.6B |
SWAV $12.6B |
PEN $10.9B |
MASI $8.4B |
GKOS $5.5B |
NARI $4.7B |
INSP $4.5B |
TMDX $4.1B |
TNDM $1.5B |
IART $1.1B |
INMD $1.0B |
Gross Margin | 72% | 7/16 | SWAV 87% |
NARI 87% |
INSP 85% |
EW 79% |
INMD 78% |
GKOS 73% |
PODD 72% |
ALGN 70% |
PEN 67% |
SYK 65% |
DXCM 59% |
TMDX 59% |
TNDM 56% |
IART 56% |
ABT 55% |
MASI 41% |
Profit Margin | 17% | 5/16 | ABT 84% |
EW 28% |
SWAV 25% |
INMD 23% |
PODD 17% |
INSP 15% |
DXCM 14% |
PEN 11% |
ALGN 10% |
SYK 8% |
TMDX 6% |
IART 4% |
TNDM 0% |
NARI -12% |
GKOS -32% |
MASI -58% |
EBITDA margin | 18% | 7/16 | EW 35% |
INMD 29% |
ABT 27% |
INSP 24% |
DXCM 22% |
SWAV 19% |
PODD 18% |
IART 18% |
PEN 16% |
ALGN 14% |
TMDX 13% |
SYK 9% |
TNDM 1% |
NARI -5% |
GKOS -21% |
MASI -60% |
Quarterly Revenue | $597.5 Million | 7/16 | ABT $11.0B |
SYK $6.4B |
EW $1.4B |
DXCM $1.1B |
ALGN $995.2M |
MASI $600.7M |
PODD $597.5M |
IART $442.6M |
PEN $315.5M |
TNDM $282.6M |
INSP $239.7M |
SWAV $218.8M |
NARI $153.4M |
TMDX $121.6M |
GKOS $105.5M |
INMD $77.9M |
Quarterly Earnings | $100.7 Million | 6/16 | ABT $9.2B |
SYK $546.0M |
EW $385.6M |
DXCM $151.7M |
ALGN $103.8M |
PODD $100.7M |
SWAV $55.3M |
INSP $35.2M |
PEN $33.7M |
IART $19.4M |
INMD $18.2M |
TMDX $6.9M |
TNDM $755,000 |
NARI -$18.4M |
GKOS -$33.6M |
MASI -$349.6M |
Quarterly Free Cash Flow | $0 Million | 14/16 | ABT $2.1B |
DXCM $176.8M |
INSP $62.2M |
MASI $47.5M |
PEN $45.7M |
SWAV $27.5M |
INMD $14.0M |
IART $11.2M |
TMDX $6.1M |
NARI -$995,000 |
GKOS -$1.2M |
TNDM -$38.8M |
EW -$177.3M |
PODD -$0 |
SYK -$0 |
ALGN -$0 |
Trailing 4 Quarters Revenue | $1.9 Billion | 7/16 | ABT $42.0B |
SYK $22.6B |
EW $5.7B |
DXCM $4.0B |
ALGN $4.0B |
MASI $2.1B |
PODD $1.9B |
IART $1.6B |
PEN $1.2B |
TNDM $1.1B |
INSP $802.8M |
SWAV $788.0M |
NARI $574.5M |
TMDX $441.5M |
INMD $392.4M |
GKOS $383.5M |
Trailing 4 Quarters Earnings | $418.3 Million | 6/16 | ABT $11.0B |
SYK $6.4B |
EW $1.4B |
DXCM $1.1B |
ALGN $995.2M |
MASI $600.7M |
PODD $597.5M |
IART $442.6M |
PEN $315.5M |
TNDM $282.6M |
INSP $239.7M |
SWAV $218.8M |
NARI $153.4M |
TMDX $121.6M |
GKOS $105.5M |
INMD $77.9M |
Quarterly Earnings Growth | -3% | 9/16 | ABT 479% |
INSP 139% |
TNDM 103% |
TMDX 70% |
SWAV 41% |
GKOS 9% |
EW 4% |
IART -2% |
PODD -3% |
ALGN -16% |
INMD -23% |
PEN -38% |
DXCM -41% |
SYK -52% |
NARI -681% |
MASI -1128% |
Annual Earnings Growth | 62% | 5/16 | INSP 593% |
EW 174% |
TMDX 149% |
ABT 127% |
PODD 62% |
TNDM 25% |
DXCM -7% |
SYK -7% |
INMD -7% |
GKOS -14% |
ALGN -14% |
SWAV -65% |
PEN -83% |
IART -109% |
MASI -563% |
NARI -934% |
Quarterly Revenue Growth | 17% | 7/16 | TMDX 50% |
TNDM 44% |
SWAV 36% |
GKOS 28% |
INSP 25% |
NARI 21% |
PODD 17% |
SYK 11% |
IART 11% |
PEN 11% |
MASI 9% |
DXCM 8% |
ABT 7% |
ALGN 4% |
INMD -3% |
EW -10% |
Annual Revenue Growth | 5% | 9/16 | TMDX 57% |
TNDM 41% |
SWAV 33% |
INSP 23% |
GKOS 21% |
NARI 19% |
SYK 10% |
PEN 9% |
PODD 5% |
MASI 5% |
ALGN 4% |
IART 4% |
ABT 3% |
DXCM 2% |
EW -4% |
INMD -15% |
Cash On Hand | $953.4 Million | 5/16 | ABT $7.6B |
SYK $3.7B |
EW $3.0B |
ALGN $1.0B |
PODD $953.4M |
DXCM $606.1M |
TMDX $336.7M |
PEN $324.4M |
SWAV $281.7M |
IART $246.4M |
GKOS $169.6M |
INSP $150.2M |
INMD $145.9M |
TNDM $69.2M |
NARI $41.1M |
MASI -$0 |
Short Term Debt | $83.8 Million | 5/16 | SYK $12.2B |
ABT $1.5B |
DXCM $1.2B |
IART $621.6M |
PODD $83.8M |
TNDM $58.9M |
EW $23.4M |
PEN $14.6M |
SWAV $3.7M |
TMDX $2.7M |
NARI $1.6M |
GKOS -$0 |
MASI -$0 |
ALGN -$0 |
INSP -$0 |
INMD -$0 |
Long Term Debt | $0 | 15/16 | ABT $13.5B |
IART $1.4B |
DXCM $1.3B |
SWAV $773.1M |
MASI $727.9M |
EW $676.6M |
TMDX $456.2M |
TNDM $414.7M |
PEN $208.8M |
GKOS $103.4M |
ALGN $88.2M |
NARI $31.1M |
INSP $30.0M |
INMD $5.6M |
PODD $0 |
SYK $0 |
PE | 54.52 | 6/16 | PEN 775.73 |
TMDX 115.99 |
INSP 84.15 |
SWAV 76.87 |
DXCM 58.17 |
PODD 54.52 |
SYK 50.34 |
ALGN 32.39 |
ABT 17.50 |
EW 10.96 |
INMD 5.81 |
GKOS -1.00 |
TNDM -1.00 |
MASI -1.00 |
IART -1.00 |
NARI -1.00 |
PS | 12.00 | 3/16 | SWAV 15.95 |
GKOS 14.23 |
PODD 12.00 |
TMDX 9.32 |
PEN 9.10 |
DXCM 8.31 |
NARI 8.15 |
EW 7.99 |
SYK 6.67 |
INSP 5.61 |
ABT 5.59 |
MASI 4.03 |
ALGN 3.41 |
INMD 2.60 |
TNDM 1.45 |
IART 0.65 |
PB | 18.82 | 1/16 | PODD 18.82 |
TMDX 17.99 |
SWAV 16.72 |
DXCM 15.94 |
NARI 10.77 |
PEN 9.44 |
MASI 8.02 |
GKOS 7.11 |
INSP 6.53 |
TNDM 5.84 |
ABT 4.90 |
EW 4.55 |
ALGN 3.54 |
SYK 3.51 |
INMD 1.65 |
IART 0.68 |
PC | 23.92 | 9/16 | NARI 113.84 |
DXCM 55.30 |
SWAV 44.62 |
SYK 41.25 |
PEN 33.51 |
GKOS 32.16 |
ABT 30.79 |
INSP 29.99 |
PODD 23.92 |
TNDM 22.20 |
EW 15.03 |
ALGN 13.07 |
TMDX 12.22 |
INMD 6.99 |
IART 4.28 |
MASI -1.00 |
Liabilities to Equity | 1.55 | 5/16 | TNDM 2.68 |
TMDX 2.52 |
DXCM 2.08 |
IART 1.61 |
PODD 1.55 |
MASI 1.50 |
SWAV 1.19 |
ABT 0.70 |
ALGN 0.61 |
NARI 0.60 |
PEN 0.33 |
EW 0.30 |
GKOS 0.27 |
INSP 0.17 |
INMD 0.14 |
SYK 0.00 |
ROA | 0.14 | 4/16 | EW 32% | INMD 25% | ABT 16% | PODD 14% | SWAV 10% | DXCM 9% | SYK 7% | ALGN 7% | INSP 7% | TMDX 4% | PEN 1% | IART 0% | TNDM -10% | NARI -11% | MASI -12% | GKOS -15% |
ROE | 0.35 | 2/16 | EW 42% |
PODD 35% |
ABT 28% |
INMD 28% |
DXCM 27% |
SWAV 22% |
TMDX 16% |
ALGN 11% |
INSP 8% |
SYK 7% |
PEN 1% |
IART 0% |
NARI -18% |
GKOS -19% |
MASI -29% |
TNDM -36% |
Current Ratio | 1.65 | 11/16 | INMD 8.26 |
INSP 6.81 |
GKOS 4.69 |
EW 4.36 |
PEN 4.01 |
NARI 2.66 |
ALGN 2.63 |
ABT 2.43 |
SWAV 1.84 |
MASI 1.67 |
PODD 1.65 |
IART 1.62 |
DXCM 1.48 |
TMDX 1.40 |
TNDM 1.37 |
SYK -1.00 |
Quick Ratio | 0.51 | 10/16 | PEN 775.73 |
TMDX 115.99 |
INSP 84.15 |
SWAV 76.87 |
DXCM 58.17 |
PODD 54.52 |
SYK 50.34 |
ALGN 32.39 |
ABT 17.50 |
EW 10.96 |
INMD 5.81 |
GKOS -1.00 |
TNDM -1.00 |
MASI -1.00 |
IART -1.00 |
NARI -1.00 |
Long Term Debt to Equity | 0.00 | 15/16 | TMDX} 2.00 |
TNDM} 1.58 |
SWAV} 1.03 |
IART} 0.88 |
MASI} 0.69 |
DXCM} 0.62 |
ABT} 0.28 |
PEN} 0.18 |
GKOS} 0.13 |
EW} 0.07 |
NARI} 0.07 |
INSP} 0.04 |
ALGN} 0.02 |
INMD} 0.01 |
PODD} 0.00 |
SYK} 0.00 |
Debt to Equity | 0.07 | 12/16 | TMDX 2.01 |
TNDM 1.80 |
IART 1.28 |
DXCM 1.20 |
SWAV 1.03 |
MASI 0.69 |
ABT 0.32 |
SYK 0.28 |
PEN 0.19 |
GKOS 0.13 |
NARI 0.08 |
PODD 0.07 |
EW 0.07 |
INSP 0.04 |
ALGN 0.02 |
INMD 0.01 |
Burn Rate | -11.95 | 14/16 | TMDX 27.89 |
GKOS 4.50 |
DXCM 2.93 |
TNDM 2.27 |
NARI 2.06 |
SYK 1.46 |
IART 1.29 |
MASI 0.00 |
ABT -0.92 |
INSP -4.41 |
INMD -8.12 |
EW -8.63 |
ALGN -10.41 |
PODD -11.95 |
SWAV -11.98 |
PEN -14.96 |
Cash to Cap | 0.04 | 7/16 | IART 0.23 |
INMD 0.14 |
ALGN 0.08 |
TMDX 0.08 |
EW 0.07 |
TNDM 0.05 |
PODD 0.04 |
ABT 0.03 |
GKOS 0.03 |
PEN 0.03 |
INSP 0.03 |
DXCM 0.02 |
SYK 0.02 |
SWAV 0.02 |
NARI 0.01 |
MASI 0.00 |
CCR | 14/16 | INSP 1.76 |
PEN 1.36 |
DXCM 1.17 |
TMDX 0.88 |
INMD 0.77 |
IART 0.58 |
SWAV 0.50 |
ABT 0.23 |
NARI 0.05 |
GKOS 0.04 |
MASI -0.14 |
EW -0.46 |
TNDM -51.33 |
PODD |
SYK |
ALGN |
|
EV to EBITDA | 200.70 | 6/16 | TNDM} 460.65 |
SWAV} 308.03 |
SYK} 273.99 |
TMDX} 260.82 |
PEN} 219.48 |
PODD} 200.70 |
DXCM} 146.21 |
EW} 89.74 |
ALGN} 88.05 |
ABT} 80.94 |
INSP} 77.22 |
INMD} 38.85 |
IART} 35.30 |
MASI} -25.53 |
GKOS} -241.61 |
NARI} -648.39 |
EV to Revenue | 11.54 | 3/16 | SWAV 16.58 |
GKOS 14.05 |
PODD 11.54 |
TMDX 9.59 |
PEN 9.01 |
DXCM 8.79 |
NARI 8.14 |
EW 7.58 |
SYK 7.05 |
ABT 5.77 |
INSP 5.46 |
MASI 4.38 |
ALGN 3.17 |
INMD 2.24 |
TNDM 1.83 |
IART 1.73 |